sc13dza

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0000950123-09-041478.txt : 20090908 0000950123-09-041478.hdr.sgml : 20090907 20090908085431 ACCESSION NUMBER: 0000950123-09-041478 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20090908 DATE AS OF CHANGE: 20090908 GROUP MEMBERS: JACOB CAPITAL, L.L.C. GROUP MEMBERS: RICHARD LEVY GROUP MEMBERS: VICTORY PARK SPECIAL SITUATIONS MASTER FUND, LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GLOBAL MED TECHNOLOGIES INC CENTRAL INDEX KEY: 0001009463 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 841116894 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-54591 FILM NUMBER: 091057148 BUSINESS ADDRESS: STREET 1: 12600 W COLFAX STREET 2: SUITE C-420 CITY: LAKEWOOD STATE: CO ZIP: 80215 BUSINESS PHONE: 3032382000 MAIL ADDRESS: STREET 1: 12600 WEST COLFAX AVENUE STREET 2: SUITE C-420 CITY: LAKEWOOD STATE: CO ZIP: 80125-3737 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL DATA TECHNOLOGIES INC DATE OF NAME CHANGE: 19960808 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Victory Park Capital Advisors, LLC CENTRAL INDEX KEY: 0001413834 IRS NUMBER: 208996172 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 227 WEST MONROE STREET, SUITE 3900 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-479-4947 MAIL ADDRESS: STREET 1: 227 WEST MONROE STREET, SUITE 3900 CITY: CHICAGO STATE: IL ZIP: 60606 SC 13D/A 1 c53506sc13dza.htm AMENDMENT TO SCHEDULE 13D sc13dza

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Global Med Technologies, Inc.

(Name of Issuer)

Common Stock, $.01 par value per share

(Title of Class of Securities)

37935E101

(CUSIP Number)

Scott R. Zemnick, Esq.
Victory Park Capital Advisors, LLC
227 West Monroe Street, Suite 3900
Chicago, Illinois 60606
(312) 705-2786

(Name, Address and Telephone Number of Persons Authorized to Receive Notices and Communications)

September 4, 2009

(Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. þ


*		The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

TABLE OF CONTENTS


	Item 1. Security and Issuer
	Item 4. Purpose of Transaction
	Item 7. Material to Be Filed as Exhibits
SIGNATURES
EXHIBIT INDEX
EX-99.1


CUSIP No.		37935E101

NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of Above Persons (Entities Only)

Victory Park Capital Advisors, LLC

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

SOLE VOTING POWER

NUMBER OF

- 0 -

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

4,876,765*

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

- 0 -

WITH

SHARED DISPOSITIVE POWER

4,876,765*

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,876,765*

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13.6%¹

TYPE OF REPORTING PERSON

^* Excludes 9,625,000 Common Shares issuable upon exercise of warrants to acquire 4,125,000 Common Shares and upon conversion of 5,500 shares of series A convertible preferred stock (“Preferred Shares”) of the Issuer convertible into 5,500,000 Common Shares, which warrants and Preferred Shares are subject to so-called “blocker” provisions prohibiting the holder from exercising the warrants or converting the Preferred Shares, as applicable, to the extent that such exercise or conversion would result in the holder becoming the beneficial owner of more than 9.99% of the outstanding Common Shares.

¹ This calculation is based on 35,855,357 shares of common stock (“Common Shares”) of Global Med Technologies, Inc. (the “Issuer”) outstanding as of August 11, 2009 as reported in the Issuer’s quarterly report on Form 10-Q for the quarter ended June 30, 2009 (the “6/30/09 10-Q”).

- -2-


CUSIP No.		37935E101

NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of Above Persons (Entities Only)

Victory Park Special Situations Master Fund, Ltd.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Cayman Islands

SOLE VOTING POWER

NUMBER OF

- 0 -

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

4,876,765*

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

- 0 -

WITH

SHARED DISPOSITIVE POWER

4,876,765*

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,876,765*

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13.6%²

TYPE OF REPORTING PERSON

^* Excludes 9,625,000 Common Shares issuable upon exercise of warrants to acquire 4,125,000 Common Shares and upon conversion of 5,500 Preferred Shares convertible into 5,500,000 Common Shares, which warrants and Preferred Shares are subject to so-called “blocker” provisions prohibiting the holder from exercising the warrants or converting the Preferred Shares, as applicable, to the extent that such exercise or conversion would result in the holder becoming the beneficial owner of more than 9.99% of the outstanding Common Shares.

² This calculation is based on 35,855,357 Common Shares outstanding as of August 11, 2009 as reported in the 6/30/09 10-Q.

- -3-


CUSIP No.		37935E101

NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of Above Persons (Entities Only)

Jacob Capital, L.L.C.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

Illinois

SOLE VOTING POWER

NUMBER OF

- 0 -

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

4,876,765*

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

- 0 -

WITH

SHARED DISPOSITIVE POWER

4,876,765*

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,876,765*

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13.6%³

TYPE OF REPORTING PERSON

³ This calculation is based on 35,855,357 Common Shares outstanding as of August 11, 2009 as reported in the 6/30/09 10-Q.

- -4-


CUSIP No.		37935E101

NAMES OF REPORTING PERSONS
I.R.S. Identification Nos. of Above Persons (Entities Only)

Richard Levy

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) o

(b) o

SEC USE ONLY

SOURCE OF FUNDS

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)

CITIZENSHIP OR PLACE OF ORGANIZATION

U.S.A.

SOLE VOTING POWER

NUMBER OF

- 0 -

SHARED VOTING POWER

BENEFICIALLY

OWNED BY

4,876,765*

EACH

SOLE DISPOSITIVE POWER

REPORTING

PERSON

- 0 -

WITH

SHARED DISPOSITIVE POWER

4,876,765*

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,876,765*

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

13.6%⁴

TYPE OF REPORTING PERSON

⁴ This calculation is based on 35,855,357 Common Shares outstanding as of August 11, 2009 as reported in the 6/30/09 10-Q.

-5-

Item 1. Security and Issuer.

This Amendment No. 1 to Schedule 13D (“Amendment No. 1”) relates to the common stock, par value $.01 per share (the “Common Shares”), of Global Med Technologies, Inc., a Colorado corporation (the “Issuer”). The address of the principal executive office of the Issuer is 12600 West Colfax, Suite C-420, Lakewood, Colorado 80215. This Amendment No. 1 amends and supplements, as set forth below, the Schedule 13D filed by the Reporting Persons with respect to the Issuer on December 9, 2008 (the “Schedule 13D”). All capitalized terms not otherwise defined herein have the meanings ascribed to them in the Schedule 13D. Only those items amended are reported herein.

As of September 4, 2009, the Reporting Persons (as hereinafter defined) beneficially owned an aggregate of 4,876,765 Common Shares (the “Subject Shares”), representing approximately 13.6% of the outstanding Common Shares. Each of the Reporting Persons may also be deemed to be the beneficial owner of 9,625,000 Common Shares issuable upon exercise of warrants (the “Warrants”) to acquire 4,125,000 Common Shares and upon conversion of 5,500 shares of series A convertible preferred stock, par value $0.01 per share (the “Preferred Shares”), of the Issuer convertible into 5,500,000 Common Shares. The Warrants and Preferred Shares are subject to so-called “blocker” provisions prohibiting the Reporting Persons from exercising the Warrants or converting the Preferred Shares, as applicable, to the extent that such exercise or conversion would result in the Reporting Persons becoming the beneficial owners of more than 9.99% of the outstanding Common Shares. Accordingly, based on the number of outstanding Common Shares as reported in the Issuer’s quarterly report on Form 10-Q for the quarter ended June 30, 2009 (the “6/30/09 10-Q”), the Warrants are not currently exercisable and the Preferred Shares are not currently convertible and, consequently, the 9,625,000 Common Shares issuable upon exercise of the Warrants and conversion of the Preferred Shares have not been included in the number of Subject Shares beneficially owned by the Reporting Persons.

Item 4. Purpose of Transaction.

Item 4 of the Schedule 13D is amended and supplemented as follows:

On September 4, 2009, representatives of the Reporting Persons delivered a letter (the “Letter”) to the Issuer’s board of directors indicating that the Reporting Persons are prepared to purchase all of the Issuer’s outstanding equity securities that they do not already own for $0.90 per share in cash, subject to the completion of limited, confirmatory due diligence and the negotiation of a definitive merger agreement (the “Proposal”). A copy of the Letter is attached hereto as Exhibit 1 and is incorporated herein by reference.

The Reporting Persons believe that delivery of the Letter constitutes a proposal to acquire a majority share in, or full ownership of, the Issuer. The Reporting Persons thus believe that under the Value Added Marketing Agreement between McKesson Information Solutions LLC (“McKesson”), a division of McKesson Corporation, and the

-6-

Issuer, McKesson has the right to receive notice of such offer and to make a similar offer. The Reporting Persons believe that the Issuer has no obligation to accept such offer.

The Proposal is preliminary, and remains subject to negotiation of definitive documentation; approval of the Issuer’s board of directors; approval by the shareholders of the Issuer; and satisfaction of the other conditions set forth in the Letter. As of September 4, 2009, the Issuer and its advisors have not yet had an opportunity to respond to the Letter. There can be no assurance that the proposed transactions or any other transaction will result from the Proposal. The Reporting Persons have sought and may in the future seek the views of, hold discussions with and respond to inquiries from the Issuer’s shareholders, and/or the board of directors, officers or representatives of the Issuer, as well as other persons, regarding the Proposal and alternatives thereto. In connection with the proposed transactions referenced in the Letter and other plans or proposals that the Reporting Persons may develop, the Reporting Persons may make and negotiate proposals to and with the Issuer and/or such other persons concerning the Proposal and alternatives thereto, and may enter into agreements with the Issuer and/or such other persons in connection with those negotiations and proposals. Such discussions may include one or more actions described in subsections (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to formulate plans or make proposals, and take such action with respect thereto, including any or all of the items set forth in subsections (a) through (j) of Item 4 of Schedule 13D and any other actions, as they may determine.

Item 7. Material to Be Filed as Exhibits.

Item 7 of the Schedule 13D is amended and supplemented as follows:

Letter to the Board of Directors of Global Med Technologies, Inc., dated September 4, 2009.

Joint Filing Agreement (previously filed as Exhibit 2 to the Schedule 13D filed on December 9, 2008).

-7-

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: September 8, 2009

VICTORY PARK CAPITAL ADVISORS, LLC

VICTORY PARK SPECIAL SITUATIONS MASTER FUND, LTD.


		By:		/s/ Richard Levy Name: Richard Levy
				Title: Attorney-in-Fact

JACOB CAPITAL, L.L.C.


		By:		/s/ Richard Levy Name: Richard Levy
				Title: Sole Member

RICHARD LEVY


				/s/ Richard Levy Richard Levy

-8-

EXHIBIT INDEX

Letter to the Board of Directors of Global Med Technologies, Inc., dated September 4, 2009.

Joint Filing Agreement (previously filed as Exhibit 2 to the Schedule 13D filed on December 9, 2008).

I-1

EX-99.1 2 c53506exv99w1.htm EX-99.1 exv99w1

EXHIBIT 1

September 4, 2009

Global Med Technologies, Inc.
12600 West Colfax
Suite C-420
Lakewood, CO 80215

To the Board of Directors:

As you know, Victory Park Capital Advisors, LLC (“VPC” or “we”) has been an investor in Global Med Technologies, Inc. (“GLOB” or the “Company”) since September 2007, and certain principals of VPC have been involved with investments in GLOB since December 2005 while managing investments for a previous fund. VPC currently owns the following GLOB securities: (i) preferred equity securities convertible into 5,500,000 shares of common equity; (ii) warrants exercisable for 4,125,000 shares of common equity; and (iii) 4,876,765 shares of common equity which were accumulated primarily through open market purchases. We are currently the largest shareholder and own approximately 25% of the fully-diluted economic interests in the Company, assuming conversion of our preferred equity securities and exercise of our warrants at the Company’s current share price.

In December 2008, we delivered a letter to the Board expressing our view that the Company has been unable to realize full value as a publicly-traded company and requesting that the Board explore strategic alternatives to realize the Company’s intrinsic value for shareholders, including a public auction of the Company or a buyout transaction led by VPC. In that letter, we indicated that VPC was prepared to purchase all of the Company’s outstanding equity securities. Unfortunately, the Board did not at that time initiate a public auction process.

Nine months later, we continue to believe that the equity markets do not reflect the Company’s intrinsic value and that it is incumbent upon the Board to take action to realize that value for shareholders. To that end, we are prepared to propose to purchase all of the Company’s outstanding equity securities that VPC does not already own for $0.90 per share in cash, subject to the completion of limited, confirmatory due diligence, the negotiation of a definitive merger agreement and management cooperation. We are prepared to move expeditiously to complete due diligence and begin discussions regarding appropriate transaction agreements for a negotiated transaction.

Our experience with the Board suggests that its members take very seriously their fiduciary responsibilities to the shareholders. Accordingly, in discharging their fiduciary duties, we expect the Board will engage recognized outside financial and legal advisors, fully and fairly evaluate our proposal relative to other alternatives currently available, and act in a manner that maximizes the value of the Company for its shareholders. If the Board does not pursue our proposal on a negotiated basis, the Board should initiate a public auction of the Company, and VPC would be willing to participate in that process. If the Board is unwilling to engage with VPC in good faith

227 West Monroe Street | Suite 3900 | Chicago, Illinois 60606 | P 312.701.1777 | F 312.701.0794

negotiations or begin a public auction process, we believe it is our responsibility to take our proposal directly to the Company’s shareholders, and we are prepared to do so.

We look forward to a productive process as we work with the Board to deliver full value to the Company’s shareholders. We expect that the Board will respond to this letter no later than ten business days from the receipt of this letter.


		Sincerely,

		/s/ Richard Levy
		Richard Levy
		Managing Principal
		Victory Park Capital Advisors, LLC

227 West Monroe Street | Suite 3900 | Chicago, Illinois 60606 | P 312.701.1777 | F 312.701.0794

GRAPHIC 3 c53506c5350600.gif GRAPHIC begin 644 c53506c5350600.gif M1TE&.#EAH0!.`,0``+^_O\_/SW]_?Y^?GZ^OKS\_/V]O;U]?7X^/CT]/3R\O M+P````\/#Q\?'T!`0("`@%!04-_?W^_O[____P`````````````````````` M`````````````````````````"'Y!```````+`````"A`$X```7_X!2)Y&2> M:*JN$\"VDR2/$BR-;ZZO-26!9%F5C116X^R)YF7VT-#U%2)0`)1*$E1A5R.>E3%-CH6D/P&)A34!HBNK0E`WL$D1C@,!EX2T,0)? M,4FN,':DI$T#NJE`$08KN$S'F#*(8U,%HV:Z`'_'+#4``Q-JPX4!,@'+N3$( MMLQ="$27/FB#6K!=1&CBI&FKY'KX(@0P)9MQ(-R.6>6LL4`"2@Z]?*7`S5LS MPH4R%HK<*'P1[H:`(1-O;(1(DL4J30G\_XE`,-(7/@0&=PSXV&(:CQJ#;I7< M641&@S7PP#40:**/%3(C!'P;4H,FSZ=P^K`L@RO)@APC6$[-=":"4Q6N(@1` MH`BJ64/@3I7I`ZYE'R8'6K[(8HXC#6!G\P())9<%E1H1%.0`X$+"``-E[YT@ MB]'5&[V00VDB\T?$`:S)&-*;D7A/HZ61]3H#_8Y*A(EV51$=+(?T"34W4H;. MZS"F#G=_7<,!')#,/\%@?4UP-SNOV$9]41@]OD07<25G9'P]$;!`NV)\)YX^L6P5T48D>#5C%#-P^,5)QQP MY&L2)'(@3/D-`-,O5=C#A@\`$IG76#KT,,"+NR$)0U%+X=1/B;C,Y<5[6D)U MPQEJDD,B=6#T4=@-KJ0AF4T8O0EFF_FHIF9:6ASW0SDGG=%/;UO<("6@9_V) M@$?X^36('1PJ]^8GF>BW)*2$Z-F*%X_UA$L>IS'G3S$<2%%!1_TMACMA!%8$QB/U1#CQ0`*/D@&J+(2"YFM)#6#90/Z0?M3MUP M-V\AH%GG8Z$_#+E3=,W^6T@3Y_B8B+]#O"7!K:7T<)JR"K\0`;:A;,NL1?O" M2L?`&5.D"&#)EG$F`*7RRT>E)7=9U,S1T-@MQKX9R)F\,0W"A-5Y9<1*T8I MI7!2>^EQ8,-F'??7R>'AX,PLB,`,:!>3J:1*V+2)P`0YQ^;Q0R(";`UI#U.$ MF@S@;N)CA<0^.T,`SS,>N%86",`=&6#6P50;_]`Q&STCWLJ5KOKJK+?N^NNP MQR[[[*L[\U8?Z)'M@C>ZZVCN>\YX8UI%!(YI_!S,J$!ZZJ7/),#ST$^``7T?T`!!T!``NCWO_X!L'/P@0_]$M`]!CJ0@?);GP#$I[3759!V&,R@ M!C<(&%J2PC;HX;GQ7(8*BB-"`%JF!`B8@(8K,8&W MNA2U?)#&7+X!(5A\X#'*.,4A2SC'`5SC#27,1"]708$!BA:!$MH%*FHC@@/T MXSE'!(@2`GB.=)X!%(5LT`=P. MM#WF9<1']KH+"EA&M:FPK"P$:&$`HGB"+-[)()=REP2@=1$57,X(M+!)\0;W MP\70L$)MF\`2%[,* M1A!2C]N2!.WR``(@]+TFD(4!*S'4="2P@/02`5M92L*LI@(9].5``(R)@PRD0 M1T$G0,\-*W7.$]03!0*H`@X!P`!?6M$SFH/1M`Q:%FQFXP4+L)`\L'>")P[_ M,HK,;,&+9N!-:)9`71VE"0X-NB]AI@"%$_B)"A)`G.WPH%*`(8%34)J,OW!# MB+ID!`%*-<$43&P*G[1&61C0R`<,T@1,3<%2;M4_%/"4&OI9:3Q-P,U!KG0" M!05KJ;RIS'&M8)8!/@8=Q2^]7EDJP+ZP:]ICK^<=!1[M72^SBX0M:MMR0A```[ ` end

Jacob Capital, L.L.C., its Manager

/s/ Richard Levy

Name: Richard Levy

Title: Sole Member